Skip to main content
. 2017 Jul 17:84–95.e10. doi: 10.1016/B978-0-323-35761-6.00008-0

TABLE 8.2.

Comparison of Polyclonal and Monoclonal Antibody Therapy

Polyclonal Antibodies Monoclonal Antibodies
Advantages Polyvalent specificity
Multiple isotypes with different effector functions
High specific activity
Standardized potency
Unlimited availability
Minimal biohazard potential

Disadvantages Low specific activity
Broad variation in potency
Limited availability
Biohazard risk of human blood products
Monovalent specificity
Single isotype
Potential to select for escape mutants